Skip to main content

Table 1 Distribution of blood groups for the characteristics of PCOS participants

From: Menstrual disorder is associated with blood type in PCOS patients: evidence from a cross-sectional survey

Variables

Blood Type

P-valuea

A

AB

B

O

Age

29 (27,32)

30 (27,32)

28 (26,31)

29 (27,32)

0.54

BMI

23 (20.25,27.25)

23.9 (21.7,26.5)

25.2 (22.2,28.9)

25.7 (22.3,29.3)

0.033

Present regularity of menstruation

0.665

Irregular

45 (75%)

28 (80%)

81 (81.82%)

71 (75.53%)

 

Regular

15 (25%)

7 (20%)

18 (18.18%)

23 (24.47%)

 

Present duration of menstruation

  

0.033

< 10 days

56 (94.92%)

31 (88.57%)

95 (97.94%)

86 (98.85%)

 

≥ 10 days

3 (5.08%)

4 (11.43%)

2 (2.06%)

1 (1.15%)

 

Present level of menstruation

0.036

Light

19 (32.2%)

17 (47.22%)

32 (31.68%)

20 (22.22%)

 

Normal

38 (64.41%)

16 (44.44%)

65 (64.36%)

59 (65.56%)

 

Heavy

2 (3.39%)

3 (8.33%)

4 (3.96%)

11 (12.22%)

 

TG

1.06 (0.8,1.5)

1.14 (0.88,1.92)

1.34 (0.88,1.85)

1.45 (0.92,2.04)

0.09

HDL

1.31 (1.08,1.54)

1.27 (1.14,1.36)

1.21 (1.02,1.38)

1.19 (1,1.41)

0.148

HOMA.IR

2.04 (1.34,3.09)

2.12 (1.52,3.46)

2.45 (1.64,3.76)

2.41 (1.69,3.42)

0.392

PRL

11.7 (8,15.8)

11.05 (8.2,13.1)

10.9 (7.95,14.25)

10.2 (8.28,13.32)

0.773

FSH

6.13 (5.38,6.73)

6.52 (5.25,7.33)

6.3 (5.44,7.74)

5.16 (4.14,6.14)

< 0.001

LH

7.13 (3.46,12.38)

7.66 (5.07,12.75)

7.2 (4.31,11.9)

5.11 (2.94,8.79)

0.022

LH/FSH

1.17 (0.64,1.98)

1.37 (0.91,1.94)

1.03 (0.64,1.79)

1.14 (0.56,1.71)

0.464

E2

174 (128,222)

161 (119,216.5)

159 (122,192)

219 (168.5,304)

< 0.001

T

1.02 (0.69,1.45)

1.25 (0.69,1.57)

0.95 (0.69,1.39)

1.15 (0.74,1.64)

0.177

A2

13.4 (9.42,16.7)

13.65 (9.31,15.37)

13.05 (9.1,17.6)

13.1 (9.01,18.72)

0.949

SAS

45 (41.25,51.25)

43.75 (38.75,51.88)

43.75 (40,50)

45 (40,48.75)

0.739

SDS

45 (40,56.88)

43.75 (36.25,53.12)

47.5 (38.75,56.25)

45 (38.75,52.5)

0.448

PSS

25.91 ± 7.56

23.33 ± 7.79

24.29 ± 7.35

24.35 ± 7.63

0.341

  1. aUnivariate analysis included the one-way ANOVA, the Kruskal-Wallis test and χ2 test or Fisher’s exact test
  2. *BMI, body mass index; TG, triglyceride; HDL, high density lipoprotein; HOMA-IR: Homeostasis model assessment of insulin resistance, calculated by using the formula: [FINS (µU/mL) × FPG (mmol/L)]/22.5; PRL, prolactin; FSH, follicle-stimulating hormone; LH, luteinizing hormone; E2, estradiol; T, testosterone; A2, androstenedione; SAS, self-rating anxiety scale; SDS, self-rating depressive scale; PSS, perceived stress scale